SV40 and cell cycle perturbations in malignant mesothelioma

J R Testa1, A Giordano

  • 1Human Genetics Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA. JR.Testa@fccc.edu

Insights

Simian virus 40 (SV40) may contribute to malignant mesothelioma (MM) by disrupting cell cycle regulation. SV40 oncoproteins interact with tumor suppressors like pRb and p53, potentially driving MM development.

Area of Science:

  • Oncology
  • Virology
  • Molecular Biology

Background:

  • Malignant mesothelioma (MM) is primarily linked to asbestos exposure.
  • Emerging evidence suggests Simian Virus 40 (SV40) involvement in some MM cases.
  • Tumorigenesis requires multiple genetic events, including cell cycle deregulation.

Purpose of the Study:

  • To review the role of SV40 in malignant mesothelioma etiology.
  • To explore SV40's interaction with cell cycle regulatory pathways.
  • To discuss how SV40 contributes to mesothelial cell neoplastic transformation.

Main Methods:

  • Review of epidemiological and molecular genetic studies.
  • Analysis of SV40 oncoprotein interactions with tumor suppressors (pRb, p53).
  • Examination of genetic alterations in MM, including p16(INK4a) and p14(ARF) inactivation.

Main Results:

  • SV40 oncoproteins interact with the retinoblastoma (Rb) protein family, altering cell cycle control.
  • SV40 inhibits the p53 tumor suppressor, compromising cell cycle checkpoints.
  • SV40 large T antigen binds to and inactivates pRb and p53 in human MM specimens.
  • Inactivation of p16(INK4a) and p14(ARF), key cell cycle regulators, is common in MM.

Conclusions:

  • SV40-oncosuppressor interactions disrupt pRb- and p53-dependent cell cycle pathways.
  • These disruptions contribute to the neoplastic transformation of human mesothelial cells.
  • SV40 is a potential etiological factor in a subset of malignant mesothelioma cases.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...